BackPear Therapeutics Overview

Pear Therapeutics Research & Development

Research & Development expenses for PEAR.

Quarterly R&D Expenses

$11.94M
↓ 67.76% YoY

As of Dec 31, 2022

Annual R&D Expenses (TTM)

$48.31M
↑ 30.43% YoY

Trailing 12 months ending Dec 31, 2022

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin